ArticleBMC medical imaging2026
Prognostic value of deep learning-based coronary artery calcium score and quantitative pneumonia burden in patients hospitalized with COVID-19.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere COVID-19 outcomes are influenced by both pulmonary involvement and underlying cardiovascular disease. Deep learning (DL) techniques can rapidly quantify pneumonia burden and coronary artery calcium score (CACS) from routine chest computed tomography (CT), offering potential for early risk stratification. We aimed to evaluate the prognostic value of DL-based CACS and quantitative pneumonia burden for predicting in-hospital mortality in patients hospitalized with COVID-19.
methodsThis single-center retrospective study evaluated 1,050 PCR-confirmed SARS-CoV-2 patients hospitalized between 1 September and 31 December 2020 who underwent chest CT. DL algorithms quantified pneumonia burden and CACS. CTs from 300 patients were used to train and tune the CACS model; 388 patients formed the test cohort. Patients were stratified by CACS into six CACS categories. The primary outcome was in-hospital mortality. Multivariate logistic regression and ROC analysis assessed predictive performance.
resultsIn-hospital mortality occurred in 74 patients. Mortality increased with higher CACS: 8.2% in CACS = 0 vs. 27.3% in CACS > 1,000. A CT-based model including pneumonia burden and CACS demonstrated strong predictive power (AUC: 0.77; 95%CI: 0.71–0.83), which improved with the addition of clinical variables (AUC: 0.85; 95%CI: 0.81–0.90; p < 0.001). However, CACS did not independently predict mortality beyond age. In multivariate analysis, pneumonia burden (OR: 1.05; 95%CI: 1.04–1.07; p < 0.001), age, and immunodeficiency remained significant predictors.
conclusionsDL-based CT quantification of pneumonia burden and CACS provides strong prognostic value for in-hospital mortality. Pneumonia burden remains an independent predictor, while CACS does not offer additional value over age.
trial registrationNot applicable. This study is a retrospective observational analysis approved by the Semmelweis University Ethics Committee (SE RKEB: 256/2020).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.